Where does Egenesis's cap table come from?

Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Egenesis's 5 recorded funding rounds.

Premier Alternatives

Egenesis

Cambridge, MA · Founded 2015 · Privately Held (backing)

Developer of human-compatible engineered organs and cells designed to address the global shortage of transplantable organs. Egenesis is based in Cambridge, MA and was founded in 2015. Its last known valuation is $330 million. It has raised $454 million across 5 recorded rounds; the latest was a $25.4 million debt round in Feb 2024.

Last price · $/share

—

Implied valuation

$330.0M

Total raised

$454.0M

Last round

Debt

Feb 2024

Cap table — not yet on record

Egenesis's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.

Pro members can request priority coverage with a 48-hour turnaround.

Free account

More of Egenesis with a free account

·The complete investor list: 37 names
·Watch Egenesis: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

Frequently asked about Egenesis

Where does Egenesis's cap table come from?: Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Egenesis's 5 recorded funding rounds.